Terry Magnuson Joins PPD Board; Brings Genetics Expertise

21-Mar-2001

PPD, Inc. (Nasdaq: PPDI) announced today that Terry Magnuson, Ph.D., professor and founding chair of the department of genetics at the University of North Carolina School of medicine, has joined its board of directors. Magnuson also serves as the director of the Carolina Center of Genome Sciences and is a member of the Lineberger Cancer Center.

"Having a professional of the stature of Dr. Magnuson on our board will be an asset as we continue to incorporate genomics in drug discovery and development," said Fred Eshelman, chief executive officer of PPD. "We look forward to his valuable insight and expertise in genetic sciences."

Magnuson, 50, has more than 19 years of experience in genetics. Prior to joining the University of North Carolina as the Sarah Graham Kenan professor and chair of the department of genetics in 2000, Magnuson held a number of positions in genetics over his sixteen years at Case Western Reserve University (CWRU) School of Medicine. He continues to serve as adjunct professor at CWRU. From 1982 to 1984, he was the assistant research geneticist in the department of pediatrics at the University of California in San Francisco.

Magnuson serves on numerous boards and scientific advisory panels, including the Board of Trustees of the Society of Developmental Biology, and Secretariat of the International Mammalian Genome Society, for which he was a founding member. Included in his many appointments on review panels and advisory boards for the National Institutes of Health, Magnuson served on the Genetic Basis of Disease Review Committee from 1990 to 1995, which he chaired in his last two years of service. For many years, he also served as director of the Cold Spring Harbor Laboratory summer course entitled "Molecular Embryology of the Mouse." In addition, Magnuson sits on a number of editorial boards and is the co-editor-in-chief for the peer-review journal, genesis: The Journal of Genetics and Development.

Magnuson earned his bachelor's of science degree from the University of Redlands in California and his doctorate degree from the Sloan-Kettering Division of the Cornell Graduate School of Medical Sciences. His postgraduate work was conducted at the University of California in San Francisco.

PPD, Inc. is a leading global provider of discovery and development services for the pharmaceutical and biotechnology industries. With a corporate mission to help clients maximize the return on their massive R&D investments, PPD provides innovative technologies, therapeutic expertise and comprehensive services for drug discovery and preclinical programs, Phase I-IV clinical development and post-market support. The company has more than 3,700 professionals in 47 facilities in 19 countries around the world. For more information on PPD, see the Web site at http://www.ppdi.com.

https://www.chemeurope.com/en/news/2112/terry-magnuson-joins-ppd-board-brings-genetics-expertise.html